Bisacodyl
Bisacodyl structure
|
Common Name | Bisacodyl | ||
|---|---|---|---|---|
| CAS Number | 603-50-9 | Molecular Weight | 361.39100 | |
| Density | 1.2 g/cm3 | Boiling Point | 492ºC | |
| Molecular Formula | C22H19NO4 | Melting Point | 131 - 135ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
[Bowel preparation for colonoscopy: comparative study using Boston Bowel Preparation Scale].
Acta Gastroenterol. Latinoam. 42(3) , 186-92, (2012) Most comparative studies on different preparations for colonic cleanliness use unvalidated scales with terms as "excellent," "good," "fair," and "poor" which lack standardized definitions. The Boston Bowel Preparation Scale (BBPS) is a valid and simple measur... |
|
|
Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Int. J. Pharm. 409(1-2) , 9-18, (2011) κ-Carrageenan is a novel pelletisation aid with high formulation robustness and quick disintegration leading to fast drug release unlike the matrix-like release from non-disintegrating microcrystalline cellulose pellets. Compression of pellets into tablets is... |
|
|
Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer.
Gastroenterology 147(4) , 903-24, (2014)
|
|
|
Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer.
Gastrointest. Endosc. 80(4) , 543-62, (2014)
|
|
|
Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
Neurogastroenterol. Motil. 27(3) , 397-405, (2015) Prucalopride is a high-affinity 5-HT4 receptor agonist for the treatment of chronic constipation. The aims of this study were to investigate the relationship between health-related quality of life (HRQoL) and symptoms of constipation, and to assess the respon... |
|
|
Serial monitoring of the physiological effects of the standard Pico-Salax® regimen for colon cleansing in healthy volunteers.
Can. J. Gastroenterol. 26(7) , 424-8, (2012) Sodium picosulfate⁄magnesium oxide⁄citric acid (Pico-Salax, Ferring Inc, Canada) is used widely in Canada and other countries for colon cleansing before colonoscopy. It is a low-volume osmotic⁄stimulant agent with the potential to deplete intravascular volume... |
|
|
A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study.
Am. J. Gastroenterol. 108(3) , 401-9, (2013) Optimal bowel preparation is vital for the efficacy and safety of colonoscopy. The inconvenience, discomfort, required consumption of large volumes of product, and potential adverse effects associated with some bowel preparations deter patients from colonosco... |
|
|
An interesting case of bisacodyl (dulcolax)-induced chromhidrosis.
Indian J. Dermatol. Venereol. Leprol. 78(6) , 756-8, (2012)
|
|
|
The concomitant use of an osmotic laxative, magnesium sulphate, and a stimulant laxative, bisacodyl, does not enhance the laxative effect.
Eur. J. Pharm. Sci. 45(1-2) , 73-8, (2012) Patients with severe constipation are treated with combinations of several different laxatives. The purpose of this study is to examine whether the concomitant use of different laxatives enhances the laxative effect, using an osmotic laxative, magnesium sulph... |
|
|
Timing and frequency of bowel activity in patients ingesting sodium picosulphate/magnesium citrate and adjuvant bisacodyl for colon cleansing before colonoscopy.
Can. J. Gastroenterol. 25(12) , 663-6, (2011) Despite the wealth of research investigating bowel cleansing efficacy, there are very little data on the timing or frequency of bowel movements after each agent is ingested.To examine the effect of each component of a three-day combined sodium picosulphate⁄ma... |